Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr 5;7(2):30.
doi: 10.3390/antibiotics7020030.

Complex Regulatory Networks Governing Production of the Glycopeptide A40926

Affiliations
Review

Complex Regulatory Networks Governing Production of the Glycopeptide A40926

Rosa Alduina et al. Antibiotics (Basel). .

Abstract

Glycopeptides (GPAs) are an important class of antibiotics, with vancomycin and teicoplanin being used in the last 40 years as drugs of last resort to treat infections caused by Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus. A few new GPAs have since reached the market. One of them is dalbavancin, a derivative of A40926 produced by the actinomycete Nonomuraea sp. ATCC 39727, recently classified as N. gerenzanensis. This review summarizes what we currently know on the multilevel regulatory processes governing production of the glycopeptide A40926 and the different approaches used to increase antibiotic yields. Some nutrients, e.g., valine, l-glutamine and maltodextrin, and some endogenous proteins, e.g., Dbv3, Dbv4 and RpoBR, have a positive role on A40926 biosynthesis, while other factors, e.g., phosphate, ammonium and Dbv23, have a negative effect. Overall, the results available so far point to a complex regulatory network controlling A40926 in the native producing strain.

Keywords: A40926; LAL; LuxR solo; StrR; dalbavancin; dbv cluster; glycopeptide antibiotics; regulatory genes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures of O-acetyl A40926 and of dalbavancin. Only the component B0 is shown for simplicity. The chemical modification present in dalbavancin is indicated in red type.
Figure 2
Figure 2
Genetic organization of the dbv cluster. The thin black arrows indicate experimentally determined operons. Red triangles indicate experimentally determined Dbv4 binding sites, with the corresponding transcripts as red thick arrows; the thin green arrows represent the transcriptional units controlled by Dbv3. The dbv genes are grouped by functional category as indicated. See also Table 1.
Figure 3
Figure 3
Simplified model of O-acetyl A40926 biosynthesis. Note that the heptapeptide is drawn right (N-terminus) to left (C-terminus), consistent with Figure 1. Cross-links are indicated by blue (C–O–C) or red (C–C) arcs. Sugars are represented as blue hexagons. Refer to Figure 2 and Table 1 for details.
Figure 4
Figure 4
Nutrients, biosynthetic products and proteins regulating A40926 production in Nonomuraea gerenzanensis.

References

    1. Kahne D., Leimkuhler C., Lu W., Walsh C. Glycopeptide and Lipoglycopeptide Antibiotics. Chem. Rev. 2005;105:425–448. doi: 10.1021/cr030103a. - DOI - PubMed
    1. Van Bambeke F. Lipoglycopeptide antibacterial agents in gram-positive infections: A comparative review. Drugs. 2015;75:2073–2095. doi: 10.1007/s40265-015-0505-8. - DOI - PubMed
    1. Klinker K.P., Borgert S.J. Beyond vancomycin: The tail of the lipoglycopeptides. Clin. Ther. 2015;37:2619–2636. doi: 10.1016/j.clinthera.2015.11.007. - DOI - PubMed
    1. Tailhades J., Schoppet M., Greule A., Peschke M., Brieke C., Cryle M.J. A route to diastereomerically pure phenylglycine thioester peptides: Crucial intermediates for investigating glycopeptide antibiotic biosynthesis. Chem. Commun. (Camb.) 2018;54:2146–2149. doi: 10.1039/C7CC09409D. - DOI - PubMed
    1. Kittila T., Kittel C., Tailhades J., Butz D., Schoppet M., Buttner A., Goode R.J.A., Schittenhelm R.B., van Pee K.H., Sussmuth R.D., et al. Halogenation of glycopeptide antibiotics occurs at the amino acid level during non-ribosomal peptide synthesis. Chem. Sci. 2017;8:5992–6004. doi: 10.1039/C7SC00460E. - DOI - PMC - PubMed

LinkOut - more resources